These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7571451)

  • 1. Molecular genetics and biophysics of prions.
    Prusiner SB
    Uirusu; 1995 Jun; 45(1):5-42. PubMed ID: 7571451
    [No Abstract]   [Full Text] [Related]  

  • 2. BSE and prions: uncertainties about the agent.
    Chesebro B
    Science; 1998 Jan; 279(5347):42-3. PubMed ID: 9441410
    [No Abstract]   [Full Text] [Related]  

  • 3. The same prion strain causes vCJD and BSE.
    Hill AF; Desbruslais M; Joiner S; Sidle KC; Gowland I; Collinge J; Doey LJ; Lantos P
    Nature; 1997 Oct; 389(6650):448-50, 526. PubMed ID: 9333232
    [No Abstract]   [Full Text] [Related]  

  • 4. Ironing out the wrinkles in the prion strain problem.
    Grady D
    Science; 1996 Dec; 274(5295):2010. PubMed ID: 8984659
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new form of infectious action. Prions and spongiform encephalopathies].
    Suárez Fernández G
    An R Acad Nac Med (Madr); 1997; 114(2):309-23; discussion 324-30. PubMed ID: 9412247
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prions and transmissible neurodegenerative diseases].
    Domínguez García A; Mata Albert E; Salleras Sanmartí L
    Med Clin (Barc); 1998 May; 110(19):751-7. PubMed ID: 9672870
    [No Abstract]   [Full Text] [Related]  

  • 7. Structural clues to prion replication.
    Cohen FE; Pan KM; Huang Z; Baldwin M; Fletterick RJ; Prusiner SB
    Science; 1994 Apr; 264(5158):530-1. PubMed ID: 7909169
    [No Abstract]   [Full Text] [Related]  

  • 8. Insights into prion strains and neurotoxicity.
    Aguzzi A; Heikenwalder M; Polymenidou M
    Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity.
    Telling GC; Parchi P; DeArmond SJ; Cortelli P; Montagna P; Gabizon R; Mastrianni J; Lugaresi E; Gambetti P; Prusiner SB
    Science; 1996 Dec; 274(5295):2079-82. PubMed ID: 8953038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human TSE disease--viral or protein only?
    Chesebro B
    Nat Med; 1997 May; 3(5):491-2. PubMed ID: 9142109
    [No Abstract]   [Full Text] [Related]  

  • 12. PrPC Governs Susceptibility to Prion Strains in Bank Vole, While Other Host Factors Modulate Strain Features.
    Espinosa JC; Nonno R; Di Bari M; Aguilar-Calvo P; Pirisinu L; Fernández-Borges N; Vanni I; Vaccari G; Marín-Moreno A; Frassanito P; Lorenzo P; Agrimi U; Torres JM
    J Virol; 2016 Dec; 90(23):10660-10669. PubMed ID: 27654300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What are the prions?].
    Piédrola Angulo G
    An R Acad Nac Med (Madr); 2001; 118(3):599-604. PubMed ID: 11783039
    [No Abstract]   [Full Text] [Related]  

  • 14. Human BSE.
    Almond J; Pattison J
    Nature; 1997 Oct; 389(6650):437-8. PubMed ID: 9333228
    [No Abstract]   [Full Text] [Related]  

  • 15. Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers.
    Barron RM; Thomson V; Jamieson E; Melton DW; Ironside J; Will R; Manson JC
    EMBO J; 2001 Sep; 20(18):5070-8. PubMed ID: 11566872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparing to treat prions.
    Griffiths PD
    Rev Med Virol; 2002; 12(1):1-3. PubMed ID: 11787079
    [No Abstract]   [Full Text] [Related]  

  • 17. Biology and genetics of prion diseases.
    Prusiner SB
    Annu Rev Microbiol; 1994; 48():655-86. PubMed ID: 7826022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical prion infection in humans and animals.
    Hill AF; Collinge J
    Br Med Bull; 2003; 66():161-70. PubMed ID: 14522857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of spiking materials for studies on the clearance of agents of transmissible spongiform encephalopathy during plasma fractionation.
    Foster PR
    Biologicals; 2008 Mar; 36(2):142-3. PubMed ID: 17400473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of transgenic mice in the investigation of transmissible spongiform encephalopathies.
    Weissmann C; Fischer M; Raeber A; Büeler H; Sailer A; Shmerling D; Rülicke T; Brandner S; Aguzzi A
    Rev Sci Tech; 1998 Apr; 17(1):278-90. PubMed ID: 9638817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.